These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
530 related items for PubMed ID: 25283550
1. microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity. Martin EC, Rhodes LV, Elliott S, Krebs AE, Nephew KP, Flemington EK, Collins-Burow BM, Burow ME. Mol Cancer; 2014 Oct 06; 13():229. PubMed ID: 25283550 [Abstract] [Full Text] [Related]
2. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Jordan NJ, Dutkowski CM, Barrow D, Mottram HJ, Hutcheson IR, Nicholson RI, Guichard SM, Gee JM. Breast Cancer Res; 2014 Jan 23; 16(1):R12. PubMed ID: 24457069 [Abstract] [Full Text] [Related]
5. Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Breuleux M, Klopfenstein M, Stephan C, Doughty CA, Barys L, Maira SM, Kwiatkowski D, Lane HA. Mol Cancer Ther; 2009 Apr 23; 8(4):742-53. PubMed ID: 19372546 [Abstract] [Full Text] [Related]
6. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK, Pizzo SV. PLoS One; 2012 Apr 23; 7(12):e51735. PubMed ID: 23272152 [Abstract] [Full Text] [Related]
9. Estrogen receptor alpha and beta regulate actin polymerization and spatial memory through an SRC-1/mTORC2-dependent pathway in the hippocampus of female mice. Zhao Y, He L, Zhang Y, Zhao J, Liu Z, Xing F, Liu M, Feng Z, Li W, Zhang J. J Steroid Biochem Mol Biol; 2017 Nov 23; 174():96-113. PubMed ID: 28789972 [Abstract] [Full Text] [Related]
16. Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo. Yang J, Ikezoe T, Nishioka C, Ni L, Koeffler HP, Yokoyama A. Exp Hematol; 2010 Aug 23; 38(8):666-76. PubMed ID: 20382200 [Abstract] [Full Text] [Related]
19. Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. Tamburini J, Chapuis N, Bardet V, Park S, Sujobert P, Willems L, Ifrah N, Dreyfus F, Mayeux P, Lacombe C, Bouscary D. Blood; 2008 Jan 01; 111(1):379-82. PubMed ID: 17878402 [Abstract] [Full Text] [Related]
20. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis. Wen ZH, Su YC, Lai PL, Zhang Y, Xu YF, Zhao A, Yao GY, Jia CH, Lin J, Xu S, Wang L, Wang XK, Liu AL, Jiang Y, Dai YF, Bai XC. Oncogene; 2013 Jan 10; 32(2):160-70. PubMed ID: 22349822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]